Pfizer-BioNTech coronavirus vaccine:
The refrigeration problem no one is talking about.

The use of this molecule in a vaccine poses a distribution logistical problem: how to keep the shot viable. That’s because these vaccine candidates have to be kept ultra cold, minus-112-degrees-Fahrenheit cold.

marketplace.org/2020/09/29/cov

And

discovermagazine.com/health/ke

@corlin The distribution of this particular vaccine is a heavy lift.

@flygande_ren @corlin Nearly immposssible since I don’t know if there are -70C refrigerator trucks that can sustain that temp for more than 24 hours. The consumption of coolant and gas would be daunting.

@VelvetDuchess @flygande_ren

Not just the distribution, but the whole process of administering the two doses. Brand new protocols need to be developed, tested, and reviewed. Then train up 10's of thousands of healthcare workers.

This ain't your flu shot.....

@corlin @flygande_ren What about the 10% that don’t develop immunity? What are they supposed to do? There’s no pre-screen for success. So it’s just wasted?

Follow

@VelvetDuchess @flygande_ren

I am sure it will end up on a gradient. 10% with no immunity, and up to 50% with some immunity, and some number with total immunity.... that way stage 3 is so important, and can not be rushed.

But yes there will be people that get the vaccine, and develop no immunity. and that dose will be wasted.

Sign in to participate in the conversation

CounterSocial is the first Social Network Platform to take a zero-tolerance stance to hostile nations, bot accounts and trolls who are weaponizing OUR social media platforms and freedoms to engage in influence operations against us. And we're here to counter it.